| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aggregation Kinetics for IgG1-Based Monoclonal Antibody Therapeutics
|
Singla, A.
|
|
2016
|
18 |
3 |
p. 689-702
|
artikel
|
| 2 |
A Kinetic Degradation Study of Curcumin in Its Free Form and Loaded in Polymeric Micelles
|
Naksuriya, Ornchuma
|
|
2015
|
18 |
3 |
p. 777-787
|
artikel
|
| 3 |
Analytical Similarity Assessment in Biosimilar Studies
|
Chow, Shein-Chung
|
|
2016
|
18 |
3 |
p. 670-677
|
artikel
|
| 4 |
BCS Biowaivers: Similarities and Differences Among EMA, FDA, and WHO Requirements
|
Davit, Barbara M.
|
|
2016
|
18 |
3 |
p. 612-618
|
artikel
|
| 5 |
Controlled Release of Chitosan and Sericin from the Microspheres-Embedded Wound Dressing for the Prolonged Anti-microbial and Wound Healing Efficacy
|
Aramwit, Pornanong
|
|
2016
|
18 |
3 |
p. 647-658
|
artikel
|
| 6 |
Determination of Cellular Processing Rates for a Trastuzumab-Maytansinoid Antibody-Drug Conjugate (ADC) Highlights Key Parameters for ADC Design
|
Maass, Katie F.
|
|
2016
|
18 |
3 |
p. 635-646
|
artikel
|
| 7 |
Development of a Physiologically Based Pharmacokinetic Model to Predict Disease-Mediated Therapeutic Protein–Drug Interactions: Modulation of Multiple Cytochrome P450 Enzymes by Interleukin-6
|
Jiang, Xiling
|
|
2016
|
18 |
3 |
p. 767-776
|
artikel
|
| 8 |
Does the Systemic Plasma Profile Inform the Liver Profile? Analysis Using a Physiologically Based Pharmacokinetic Model and Individual Compounds
|
Li, Rui
|
|
2016
|
18 |
3 |
p. 746-756
|
artikel
|
| 9 |
Erratum to: Dissolution Similarity Requirements: How Similar or Dissimilar Are the Global Regulatory Expectations?
|
Diaz, Dorys Argelia
|
|
2015
|
18 |
3 |
p. 792
|
artikel
|
| 10 |
Establishing the Quantitative Relationship Between Lanreotide Autogel®, Chromogranin A, and Progression-Free Survival in Patients with Nonfunctioning Gastroenteropancreatic Neuroendocrine Tumors
|
Buil-Bruna, Núria
|
|
2016
|
18 |
3 |
p. 703-712
|
artikel
|
| 11 |
Evaluating In Vivo-In Vitro Correlation Using a Bayesian Approach
|
Qiu, Junshan
|
|
2016
|
18 |
3 |
p. 619-634
|
artikel
|
| 12 |
Gut Wall Metabolism. Application of Pre-Clinical Models for the Prediction of Human Drug Absorption and First-Pass Elimination
|
Jones, Christopher R.
|
|
2016
|
18 |
3 |
p. 589-604
|
artikel
|
| 13 |
Pediatric Biopharmaceutical Classification System: Using Age-Appropriate Initial Gastric Volume
|
Shawahna, Ramzi
|
|
2016
|
18 |
3 |
p. 728-736
|
artikel
|
| 14 |
Pharmacodynamic Model of Hepcidin Regulation of Iron Homeostasis in Cynomolgus Monkeys
|
Krzyzanski, Wojciech
|
|
2016
|
18 |
3 |
p. 713-727
|
artikel
|
| 15 |
Pharmacogenomic Biomarkers: an FDA Perspective on Utilization in Biological Product Labeling
|
Schuck, Robert N.
|
|
2016
|
18 |
3 |
p. 573-577
|
artikel
|
| 16 |
Preclinical Pharmacokinetics Study of R- and S-Enantiomers of the Histone Deacetylase Inhibitor, AR-42 (NSC 731438), in Rodents
|
Cheng, Hao
|
|
2016
|
18 |
3 |
p. 737-745
|
artikel
|
| 17 |
Recent Advances in Application of Pharmacogenomics for Biotherapeutics
|
Mahajan, Pramod B.
|
|
2016
|
18 |
3 |
p. 605-611
|
artikel
|
| 18 |
Regulator of G Protein Signaling 17 as a Negative Modulator of GPCR Signaling in Multiple Human Cancers
|
Hayes, Michael P.
|
|
2016
|
18 |
3 |
p. 550-559
|
artikel
|
| 19 |
Regulator of G-protein Signaling (RGS)1 and RGS10 Proteins as Potential Drug Targets for Neuroinflammatory and Neurodegenerative Diseases
|
Lee, Jae-Kyung
|
|
2016
|
18 |
3 |
p. 545-549
|
artikel
|
| 20 |
Regulatory Perspectives on Strength-Dependent Dissolution Profiles and Biowaiver Approaches for Immediate Release (IR) Oral Tablets in New Drug Applications
|
Suarez-Sharp, Sandra
|
|
2016
|
18 |
3 |
p. 578-588
|
artikel
|
| 21 |
Reserpine Inhibit the JB6 P+ Cell Transformation Through Epigenetic Reactivation of Nrf2-Mediated Anti-oxidative Stress Pathway
|
Hong, Bo
|
|
2016
|
18 |
3 |
p. 659-669
|
artikel
|
| 22 |
RGS6 as a Novel Therapeutic Target in CNS Diseases and Cancer
|
Ahlers, Katelin E.
|
|
2016
|
18 |
3 |
p. 560-572
|
artikel
|
| 23 |
The Population Pharmacokinetics of d-β-hydroxybutyrate Following Administration of (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate
|
Shivva, Vittal
|
|
2016
|
18 |
3 |
p. 678-688
|
artikel
|
| 24 |
Tissue Penetration of a Novel Spectinamide Antibiotic for the Treatment of Tuberculosis
|
Madhura, Dora Babu
|
|
2016
|
18 |
3 |
p. 788-791
|
artikel
|
| 25 |
Use of the Biopharmaceutics Drug Disposition Classification System (BDDCS) to Help Predict the Occurrence of Idiosyncratic Cutaneous Adverse Drug Reactions Associated with Antiepileptic Drug Usage
|
Chan, Rosa
|
|
2016
|
18 |
3 |
p. 757-766
|
artikel
|
Tijdschrift beschrijving